<DOC>
	<DOCNO>NCT00428441</DOCNO>
	<brief_summary>Optimal duration oral anticoagulant therapy patient recurrent episode venous thromboembolism ( VTE ) matter debate recommendation base inadequate evidence . More 12 month treatment currently recommend , grade recommendation low . The PROLONG study recently evaluate predictive role D-dimer measurement withhold oral anticoagulant treatment patient first episode VTE . Patients positive D-dimer significantly high incidence VTE recurrences patient negative D-dimer required resumption antithrombotic treatment . Based result previous cohort study , appear safe withhold treatment patient negative D-dimer value continue treatment patient alter D-dimer level . Aim study therefore assess negative predictive value D-dimer also patient recurrent VTE evaluate clinical utility approach patient setting .</brief_summary>
	<brief_title>D-dimer Predict Recurrence Patients With Multiple Episodes Venous Thromboembolism</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Fibrin fragment D</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients least two episode objectively document venous thromboembolism ( least one proximal deep vein thrombosis pulmonary embolism ) Ongoing treatment oral anticoagulant least ) 12 month case idiopathic DVT last event ; b ) 6 month case Age &gt; 18 year Informed consent provide Pregnancy/puerperium One episodes massive pulmonary embolism Last event isolate idiopathic pulmonary embolism Two idiopathic VTE event First degree relative recurrent VTE Right ventricular disfunction pulmonary hypertension Active cancer Antiphospholipid antibodies syndrome Antithrombin deficiency Homozygous Factor V Leiden G20210A prothrombin mutation Heterozygous Factor V Leiden G20210A prothrombin mutation Concomitant congenital thrombophilic mutation Concomitant indication long term oral anticoagulant treatment Severe cardiorespiratory insufficiency Severe liver renal disease ( creatinine clearance &gt; 2 mg/dL ) Limited life expectancy Geographic inaccessibility</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>D-dimer</keyword>
	<keyword>Recurrence</keyword>
	<keyword>Venous thromboembolism</keyword>
</DOC>